Bangkok IMCAS Asia 2027: congress overview

Bangkok IMCAS Asia is the 20th edition of the IMCAS Asia congress for dermatology, plastic surgery and aesthetic medicine. The organiser lists 4–6 June 2027 at Queen Sirikit National Convention Center, Bangkok, Thailand. It combines scientific education with an exhibition for medical-aesthetic companies and practitioners.

The 2027 edition is described as a milestone edition at a new, larger venue. The detailed programme and visitor registration were marked as coming soon when checked; confirm the latest details before planning.

Why Bangkok IMCAS Asia matters

Clinical learning

The 2027 page highlights regenerative therapies, advanced energy-based devices and precision techniques tailored to Asian morphologies. These themes let clinicians consider emerging approaches alongside the needs and standards of their own practices.

Science and technology together

The exhibition gives practitioners a place to discuss products with industry representatives alongside the scientific programme. Visitors can ask about intended use, evidence and safety; exhibitors can explain their technologies without implying that a demonstration replaces clinical evaluation.

Previous edition in figures

The organiser's 2026 report recorded 4,048 participants, 131 exhibitors, 344 speakers, 107 sessions, participants from 93 represented countries, 15 themes, eight rooms, 853 presentations and 153 learning hours. These figures describe 2026, not a forecast for 2027.

The 2026 report said 71% of sessions were non-sponsored and 29% sponsored. An organiser-reported evaluation by 898 delegates said 96% did not perceive commercial bias during scientific sessions. These are reported survey findings; review sponsorship and evidence context session by session.

Who should visit Bangkok IMCAS Asia?

Dermatologists and aesthetic physicians

Use the announced themes to prioritise questions on regenerative therapies, energy-based devices and techniques tailored to Asian morphologies. Consider evidence, indications, safety and training in relation to your own practice.

Plastic surgeons

Compare surgical and non-surgical perspectives across plastic surgery and aesthetic medicine. The 2026 report lists sessions on anatomy, injectables complications, Korean aesthetics and longevity science; these are examples, not a confirmed 2027 schedule.

Researchers and educators

The reported 2026 programme included 853 presentations across 15 themes and eight rooms. Researchers may use the congress to follow clinical questions and identify topics for further study; confirm the 2027 programme when released.

Medical students and early-career doctors

A congress spanning scientific sessions and an exhibition can help build an overview of dermatology, plastic surgery and aesthetic medicine. Note unfamiliar methods and follow up through qualified educators and clinical sources.

What can you find at Bangkok IMCAS Asia?

2027 focus announced by the organiser

• Regenerative therapies
• Advanced energy-based devices
• Precision techniques tailored to Asian morphologies
• Dermatology, plastic surgery and aesthetic medicine

The organiser describes live demonstrations, expert-led panels and hands-on workshops. Individual sessions, speakers and timings were not yet published on the page checked.

Examples from the 2026 programme

• Anatomy on Cadaver workshops on the forehead and temple, and mid-face, periorbital area and nose
• Botulinum toxin, injectables complications and case-based management
• Current concepts in Korean aesthetics
• Non-invasive aesthetics, including HIFU and radiofrequency
• Aging beyond aesthetics and longevity science

These are previous-edition examples, not promises for 2027.

What makes Bangkok IMCAS Asia distinctive?

It connects a cross-specialty scientific congress with a medical-aesthetics exhibition. The 2027 edition is identified as the 20th IMCAS Asia and highlights regenerative therapies, devices and clinical techniques for Asian morphologies. The 2026 report adds scale: 131 exhibitors, 107 sessions and participation from 93 represented countries. This mix may suit clinicians seeking both scientific context and an opportunity to examine technologies.

What should you aim to achieve?

As a clinician

Choose a clinical question and compare the evidence, safety considerations and practical implications of the approaches discussed.

When evaluating technology

Prepare questions about intended use, evidence, training, maintenance, consumables and regulatory status. Compare supplier responses and separate verified specifications from promotional claims.

As a researcher or early-career doctor

Select a few themes, note methods and unanswered questions, and plan follow-up reading or discussion with an educator.

How to prepare before Bangkok IMCAS Asia

1. Check registration and programme status. The official page marked registration “Register soon” and the programme “Soon” when checked. Confirm the current status before making arrangements.
2. Set a purpose. Define the clinical, research or technology question you want to examine.
3. Prioritise sessions. Once the 2027 schedule is released, mark essential sessions and alternatives, leaving time for questions and the exhibition. Do not assume the 2026 room plan will repeat.
4. Prepare evidence-focused questions. For devices, ask about intended use, evidence, safety, training, service and local regulatory requirements.
5. Plan follow-up. Record the topic, evidence or specification to verify and a clear next action after each useful discussion.

How to use the congress and exhibition

Balance sessions and exhibition visits around your goals. For a technology, note product or method → intended use → evidence → safety and training questions → follow-up. For a scientific session, record the claim, method or population discussed and what needs verification. Use the official 2027 programme and floor plan when available.

Beyond the exhibition floor

The 2026 report lists 15 themes, eight rooms, 853 presentations and 153 learning hours, including anatomy workshops, sessions on injectables complications, Korean aesthetics, non-invasive technologies and longevity science. It reports that 29% of sessions were sponsored. This gives a sense of the previous edition's range; the 2027 programme and sponsorship mix still require confirmation.

Travelling to Bangkok IMCAS Asia

The official event page names Queen Sirikit National Convention Center in Bangkok. Confirm the venue, entrance and current access arrangements with the organiser before travelling. The organiser describes this as a new, larger venue for 2027; do not rely on directions from earlier editions.

One day or several days?

The congress is scheduled for three days, 4–6 June 2027. A full visit may suit participants covering several specialties, workshops and the exhibition; a shorter visit may fit a focused objective once the timetable is available. Base your choice on the published schedule, not on assumptions about the previous edition.

After Bangkok IMCAS Asia: turn notes into decisions

Separate clinical learning, research questions and commercial follow-up. Before acting on a device or treatment, verify its specifications, evidence, safety, training, service and regulatory status. Record what needs expert review and agree on a next step for useful educational or supplier discussions.

Who should consider exhibiting at Bangkok IMCAS Asia?

The organiser positions the exhibition for industry partners presenting innovations to dermatologists, plastic surgeons and aesthetic physicians. The 2026 report recorded 131 exhibitors. The 2027 exhibit page said bookings were not yet open and were tentatively scheduled to open in November, subject to change. It listed a sponsor guide, congress map, product catalogue and sponsorship levels; confirm that current materials and terms are available.

Potential exhibitors should set a measurable objective, prepare product evidence and specifications, and be ready to discuss training, service and regulatory information. Attendance figures do not guarantee buyer access or commercial results.

Bangkok IMCAS Asia visitor checklist

Before

• Confirm registration, programme, venue and access information.
• Set a clinical, scientific or technology-evaluation objective.
• Prioritise sessions and prepare evidence-focused questions.

During

• Balance scientific sessions and exhibition time around your goal.
• Record evidence, specifications, safety questions and follow-up separately.
• Note sponsorship context where relevant.

After

• Verify important claims against suitable clinical and regulatory sources.
• Follow up on selected research, education or supplier discussions.
• Document decisions and remaining questions for expert review.

Is Bangkok IMCAS Asia worth visiting?

It is most relevant to dermatologists, plastic surgeons, aesthetic physicians, researchers and early-career doctors seeking concentrated scientific content and access to a medical-aesthetics exhibition. Published themes and 2026 figures indicate a broad cross-specialty congress, while the 2027 schedule was still pending. Value depends on matching the final programme and exhibitors to your objectives and critically evaluating clinical and commercial claims.

Bangkok IMCAS Asia 2027 at a glance

Confirmed for 2027: dates, Bangkok venue and the 20th-edition designation. The detailed programme, visitor registration and daily schedule still require current confirmation.

Plan your purpose for Bangkok IMCAS Asia

Choose the clinical question, evidence or technology decision you want to take away. Use current programme and exhibitor information to plan, then follow up on points that need verification. Learn. Compare. Question. Evaluate. Follow up.

Medical aesthetics opportunities in Thailand

Market size and demand

A 2024 U.S. International Trade Administration briefing reported that Thailand's Medical Hub Board forecast the medical-aesthetics market to reach 7.51 billion US dollars in 2027; this is a forecast published in 2024, not an observed 2027 result. The briefing also reported 7,000 aesthetic clinics nationally, including 2,000 in Bangkok, and described medical-aesthetic tourism as an established segment, citing Siam Commercial Bank. These are different measures and should not be treated as interchangeable.

Market drivers and commercial opportunities

The briefing describes demand for aesthetic treatments among local and overseas customers and identifies injections, laser procedures and cosmetic surgery among popular treatments. Device and treatment suppliers could investigate fit with clinic needs, but the figures do not establish a product-specific supply gap or purchasing volume.

• Energy-based and laser technologies: suppliers could assess clinical use and service requirements with local providers; demand, competition and product fit need validation.
• Injectable and regenerative approaches: companies may examine practitioner interest, evidence and training requirements; the source does not quantify demand for specific products.
• Distribution and clinical partnerships: manufacturers may investigate local commercial or educational partners and verify terms and responsibilities directly.

Regulations and market-entry conditions

Thailand's Food and Drug Administration states that establishments manufacturing or importing medical devices commercially must register with the Thai FDA. It classifies devices by risk and says registration requirements vary by class. Companies should determine whether a product is regulated as a medical device and verify current establishment, product-registration and advertising requirements before marketing it.

What this means for exhibitors

Exhibitors may use the congress to test whether their evidence, training and service proposition addresses practitioner questions. The market forecast and clinic count are context, not proof of accessible buyers or contracts; local registration, competition and product fit remain important checks.

What this means for visitors

Clinicians and procurement teams could compare technologies and ask about intended use, evidence, safety, training, maintenance and Thai FDA status. The market indicators may help frame questions about clinical needs, but decisions require product-specific evidence and applicable regulations.

Downloadable Files:

  راهنمای ثبت نام در نمایشگاه